Table 1.- Variants (SNPs) included in the PRS calculation
(Disease/Trait: Myeloproliferative_neoplasms)
rsID	Risk allele	Effect size
rs12339666	T	0.293
rs2201862	C	0.199
rs9376092	A	0.166
Effect size: LN(OR)

Table 2.- PRS Score distribution among populations and regions
(Disease/Trait: Myeloproliferative_neoplasms)
	count	mean	sd	se	lower.ci	upper.ci
Pyrenean regions
WEST	168	0.066	0.038	0.003	0.061	0.072
SOUTH	83	0.067	0.043	0.005	0.058	0.077
EAST	146	0.066	0.042	0.003	0.059	0.073
Populations
IBS	107	0.069	0.045	0.004	0.060	0.077
PIR	397	0.067	0.041	0.002	0.063	0.071

Table 3.- Pairwise t-test for PRS score among populations and regions
(Disease/Trait: Myeloproliferative_neoplasms)
group1	group2	n1	n2	p	p.signif	p.adj	p.adj.signif
IBS	PIR	107	397	0.651	ns	1	ns
IBS	WEST	107	168	0.683	ns	1	ns
IBS	SOUTH	107	83	0.828	ns	1	ns
IBS	EAST	107	146	0.651	ns	1	ns
WEST	SOUTH	168	83	0.889	ns	1	ns
WEST	EAST	168	146	0.950	ns	1	ns
SOUTH	EAST	83	146	0.851	ns	1	ns
* p < .05, ** p < .01, *** p < .001

Table 4.- Chi-square test comparison of percentile counts on Pyrenean regions compared to Iberian peninsula population
(Disease/Trait: Myeloproliferative_neoplasms)
Percentile rank	PIR				WEST				SOUTH				EAST
	adj.std.val	p.value	sig.val		adj.std.val	p.value	sig.val		adj.std.val	p.value	sig.val		adj.std.val	p.value	sig.val
pct95	−0.360	0.719	.	white	−1.040	0.298	.	white	−0.360	0.719	.	white	−0.820	0.412	.	white
pct75.95	−0.620	0.535	.	white	−1.820	0.069	.	white	−0.620	0.535	.	white	−0.980	0.327	.	white
pct50.75	1.780	0.075	.	white	3.570	0.000	***		1.780	0.075	.	white	3.210	0.001	**
pct25.50	0.270	0.787	.	white	0.630	0.529	.	white	0.270	0.787	.	white	−1.210	0.226	.	white
pct25	−0.960	0.337	.	white	−1.950	0.051	.		−0.960	0.337	.	white	−0.820	0.412	.	white
adj.std.val: Adjusted standardized residuals value; p.value: P value; sig.val: statistical significance, * p < .05, ** p < .01, *** p < .001; red dash to bottom: lower counts than reference; green dash to up: upper counts than reference